Compound Detail
CHEMBL4594411
XENON XE-129, HYPERPOLARIZED 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL4594411 |
| Name | XENON XE-129, HYPERPOLARIZED |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | FHNFHKCVQCLJFQ-YPZZEJLDSA-N |
| Parent Compound | CHEMBL1236802 |
| Active Moiety | CHEMBL1236802 |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
4
Known Names
9
Indications
1
Mechanisms
Molecular Properties
131.3
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2022 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| MRI contrast agent | - | - | ✓ | ✓ |
Indications
Diagnostic Imaging Idiopathic Pulmonary Fibrosis Lung Diseases, Interstitial Pulmonary Fibrosis Severe Acute Respiratory Syndrome Vascular Diseases Bronchiolitis Obliterans Respiratory Tract Diseases Alzheimer Disease
Data from ChEMBL 36 via Core Engine